{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:34:12Z","timestamp":1793025252991,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Ministry of Education and Research","award":["01GN0939"],"award-info":[{"award-number":["01GN0939"]}]},{"name":"German Ministry of Education and Research","award":["01GN0940"],"award-info":[{"award-number":["01GN0940"]}]},{"name":"SBEpo","award":["0316182D"],"award-info":[{"award-number":["0316182D"]}]},{"DOI":"10.13039\/501100000780","name":"European Community","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CASCADE","award":["FP7\u2013223236"],"award-info":[{"award-number":["FP7\u2013223236"]}]},{"name":"REBORNE"},{"name":"SyStemAge","award":["FP7-306240"],"award-info":[{"award-number":["FP7-306240"]}]},{"name":"Hessian Ministry of Higher Education, Research and the Arts"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jcyt.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T11:46:33Z","timestamp":1400586393000},"page":"128-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Standardization of Good Manufacturing Practice\u2013compliant production of bone marrow\u2013derived human mesenchymal stromal cells for immunotherapeutic applications"],"prefix":"10.1016","volume":"17","author":[{"given":"Patrick","family":"Wuchter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bieback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz P.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvard","family":"B\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Malcherek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Saffrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike C.","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Sanzenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2014.04.002_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2014.04.002_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1634\/stemcells.2006-0513","article-title":"Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism","volume":"25","author":"Gottschling","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib4","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1634\/stemcells.2007-0280","article-title":"Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors","volume":"25","author":"Wagner","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.exphem.2008.12.005","article-title":"Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansion","volume":"37","author":"Alakel","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2009.010736","article-title":"Hematopoietic stem cells in co-culture with mesenchymal stromal cells: modeling the niche compartments in vitro","volume":"95","author":"Jing","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2014.04.002_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2014.04.002_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.scr.2009.12.004","article-title":"N-cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells","volume":"4","author":"Wein","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2008.52","article-title":"Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice","volume":"5","author":"Zhou","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib11","doi-asserted-by":"crossref","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","article-title":"IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis","volume":"5","author":"Bouffi","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jcyt.2014.04.002_bib12","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A\u00a0new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jcyt.2014.04.002_bib13","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2014.04.002_bib14","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2014.04.002_bib17","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2014.04.002_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00441-007-0379-5","article-title":"Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells","volume":"328","author":"Wuchter","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","article-title":"Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood","volume":"33","author":"Wagner","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.exphem.2006.01.002","article-title":"The heterogeneity of human mesenchymal stem cell preparations: evidence from simultaneous analysis of proteomes and transcriptomes","volume":"34","author":"Wagner","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/14653240802217011","article-title":"Heterogeneity of mesenchymal stromal cell preparations","volume":"10","author":"Ho","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/14653249.2011.652809","article-title":"Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum","volume":"14","author":"Bieback","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib24","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4161\/cc.9.15.12741","article-title":"Senescence is heterogeneous in mesenchymal stromal cells: kaleidoscopes for cellular aging","volume":"9","author":"Wagner","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jcyt.2014.04.002_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00109-012-0915-y","article-title":"Mesenchymal stromal cells (MSCs): science and f(r)iction","volume":"90","author":"Bieback","year":"2012","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jcyt.2014.04.002_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib27","unstructured":"EudraLex The Rules Governing Medicinal Products in the European Union: EU Guidelines to Good Manufacturing Practice - Medicinal Products for Human and Veterinary Use SANCO\/C8\/AM\/sl\/ares(2010)1064597."},{"key":"10.1016\/j.jcyt.2014.04.002_bib28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/emboj.2013.114","article-title":"Regulation of stem cell therapies under attack in Europe: for whom the bell tolls","volume":"32","author":"Bianco","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.jcyt.2014.04.002_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcyt.2013.01.219","article-title":"Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells","volume":"15","author":"Bernardi","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1574888X11308010008","article-title":"The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking","volume":"8","author":"Balci","year":"2013","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2010.197","article-title":"Good manufacturing practices production of mesenchymal stem\/stromal cells","volume":"22","author":"Sensebe","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/hum.2011.2501","article-title":"Safety of bovine sera for production of mesenchymal stem cells for therapeutic use","volume":"22","author":"Reinhardt","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib33","unstructured":"European Medicines Agency (EMA) \/ Committee for Medicinal Products for Human Use (CHMP) Guideline on the use of bovine serum in the manufacture of human biological medicinal products 2013. EMA\/CHMP\/BWP\/457920\/2012 rev 1."},{"key":"10.1016\/j.jcyt.2014.04.002_bib34","first-page":"33","article-title":"Expansion of mesenchymal stem\/stromal cells under xenogenic-free culture conditions","volume":"129","author":"Kinzebach","year":"2013","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/stemcells.2006-0627","article-title":"Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue","volume":"25","author":"Kocaoemer","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib36","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/stem.139","article-title":"Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow","volume":"27","author":"Bieback","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2014.04.002_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/ten.tec.2013.0061","article-title":"Essential components for ex vivo proliferation of mesenchymal stromal cells","volume":"20","author":"Fekete","year":"2014","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.jcyt.2014.04.002_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14653240600920782","article-title":"Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM","volume":"8","author":"Muller","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib39","first-page":"271","article-title":"Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells","volume":"19","author":"Schallmoser","year":"2009","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.jcyt.2014.04.002_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-62703-128-8_22","article-title":"Generation of a pool of human platelet lysate and efficient use in cell culture","volume":"946","author":"Schallmoser","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1537-2995.2007.01220.x","article-title":"Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells","volume":"47","author":"Schallmoser","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2014.04.002_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/14653249.2012.655420","volume":"14","author":"Fekete","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2009.01295.x","article-title":"Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?","volume":"99","author":"Schrezenmeier","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2014.04.002_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14573\/altex.2011.4.305","article-title":"Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media","volume":"28","author":"Rauch","year":"2011","journal-title":"Altex"},{"key":"10.1016\/j.jcyt.2014.04.002_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3727\/096368910X543376","article-title":"Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability","volume":"20","author":"Crespo-Diaz","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1387\/ijdb.082663jd","article-title":"Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum","volume":"52","author":"Dahl","year":"2008","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jcp.21081","article-title":"Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine","volume":"213","author":"Lange","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib48","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1089\/ten.tea.2009.0727","article-title":"Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements","volume":"16","author":"Bieback","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jcyt.2014.04.002_bib49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/scd.2012.0051","article-title":"Cultivation in human serum reduces adipose tissue-derived mesenchymal stromal cell adhesion to laminin and endothelium and reduces capillary entrapment","volume":"22","author":"Dreher","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2014.04.002_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbmt.2010.03.017","article-title":"Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population","volume":"16","author":"Lucchini","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","article-title":"Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy","volume":"77","author":"Furlani","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/17435390903470093","article-title":"Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells","volume":"4","author":"Ramot","year":"2010","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.jcyt.2014.04.002_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2014.04.002_bib54","doi-asserted-by":"crossref","first-page":"905621","DOI":"10.4061\/2011\/905621","article-title":"Establishment of a mesenchymal stem cell bank","volume":"2011","author":"Cooper","year":"2011","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2014.04.002_bib55","doi-asserted-by":"crossref","first-page":"e43255","DOI":"10.1371\/journal.pone.0043255","article-title":"GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC","volume":"7","author":"Fekete","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jcyt.2014.04.002_bib56","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3727\/096368912X657990","article-title":"GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system","volume":"22","author":"Rojewski","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000129013","article-title":"Phenotypic characterization of mesenchymal stem cells from various tissues","volume":"35","author":"Rojewski","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jcyt.2014.04.002_bib58","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/eji.201141542","article-title":"Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function","volume":"41","author":"Abdelrazik","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2008.12.044","article-title":"Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1","volume":"451","author":"Cheng","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jcyt.2014.04.002_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/scrt214","article-title":"Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application","volume":"4","author":"Menard","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib61","doi-asserted-by":"crossref","first-page":"e72831","DOI":"10.1371\/journal.pone.0072831","article-title":"CD200R\/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human","volume":"8","author":"Varin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2014.04.002_bib62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/mt.2011.211","article-title":"Mesenchymal stem\/stromal cells (MSCs): role as guardians of inflammation","volume":"20","author":"Prockop","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib64","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcyt.2014.04.002_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbmt.2009.11.006","article-title":"Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report","volume":"16","author":"Zhou","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib67","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"Weng","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib68","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bbmt.2011.09.003","article-title":"Mesenchymal stromal cells: a new tool against graft-versus-host disease?","volume":"18","author":"Baron","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcmd.2007.06.021","article-title":"Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation","volume":"40","author":"Muller","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jcyt.2014.04.002_bib70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"Kebriaei","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib71","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nbt1109-966","article-title":"Genzyme backs Osiris, despite Prochymal flop","volume":"27","author":"Allison","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"Suppl 2","key":"10.1016\/j.jcyt.2014.04.002_bib72","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bbmt.2009.12.057","article-title":"Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD","volume":"16","author":"Martin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib73","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","article-title":"Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study","volume":"17","author":"Prasad","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib74","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1089\/scd.2012.0594","article-title":"Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls","volume":"22","author":"Menard","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2014.04.002_bib75","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib76","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib77","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2012.078055","article-title":"Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6","volume":"98","author":"Melief","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2014.04.002_bib78","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib79","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/stem.698","article-title":"Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis","volume":"29","author":"Duijvestein","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib80","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","article-title":"MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2","volume":"113","author":"Spaggiari","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib81","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2014.04.002_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/14653249.2010.542460","article-title":"A\u00a0simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential","volume":"13","author":"Rizzo","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib84","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10875-011-9581-z","article-title":"Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate","volume":"31","author":"Flemming","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib85","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1705798","article-title":"Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts","volume":"40","author":"Capelli","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib86","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2014.04.002_bib87","doi-asserted-by":"crossref","first-page":"427863","DOI":"10.1155\/2011\/427863","article-title":"Clinical Application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease","volume":"2011","author":"Lin","year":"2011","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib88","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","article-title":"Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses","volume":"112","author":"Karlsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib89","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2014.04.002_bib90","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.exphem.2012.07.011","article-title":"Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cells","volume":"40","author":"Fasslrinner","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib91","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/jcb.24193","article-title":"Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation","volume":"113","author":"Mamidi","year":"2012","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jcyt.2014.04.002_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/14653240802684194","article-title":"Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells","volume":"11","author":"Samuelsson","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib94","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/14653249.2010.507330","article-title":"Defining the risks of mesenchymal stromal cell therapy","volume":"12","author":"Prockop","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib95","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.yexcr.2007.11.017","article-title":"Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition","volume":"314","author":"Rubio","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib96","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-10-1305","article-title":"Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track: letter","volume":"70","author":"Torsvik","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib97","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib98","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1158\/0008-5472.CAN-10-2451","article-title":"Retraction: spontaneous human adult stem cell transformation","volume":"70","author":"de la Fuente","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib99","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2014.04.002_bib100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","article-title":"Risk of tumorigenicity in mesenchymal stromal cell-based therapies: bridging scientific observations and regulatory viewpoints","volume":"15","author":"Barkholt","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib101","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1634\/stemcells.2006-0108","article-title":"Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction","volume":"24","author":"Mueller","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib102","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","article-title":"The limited in vitro lifetime of human diploid cell strains","volume":"37","author":"Hayflick","year":"1965","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/14653249.2011.640669","article-title":"Population dynamics of mesenchymal stromal cells during culture expansion","volume":"14","author":"Schellenberg","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2014.04.002_bib104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/ten.teb.2009.0825","article-title":"Different facets of aging in human mesenchymal stem cells","volume":"16","author":"Wagner","year":"2010","journal-title":"Tissue Eng Part B Reviews"},{"key":"10.1016\/j.jcyt.2014.04.002_bib105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/aging.100136","article-title":"How to track cellular aging of mesenchymal stromal cells?","volume":"2","author":"Wagner","year":"2010","journal-title":"Aging"},{"key":"10.1016\/j.jcyt.2014.04.002_bib106","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1073\/pnas.89.21.10114","article-title":"Telomere length predicts replicative capacity of human fibroblasts","volume":"89","author":"Allsopp","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2014.04.002_bib107","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","article-title":"Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion","volume":"22","author":"Baxter","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2014.04.002_bib108","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.exger.2006.03.016","article-title":"Techniques in gerontology: cell lines as standards for telomere length and telomerase activity assessment","volume":"41","author":"Fehrer","year":"2006","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jcyt.2014.04.002_bib109","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A\u00a0biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2014.04.002_bib110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1474-9726.2009.00535.x","article-title":"DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells","volume":"9","author":"Bork","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.jcyt.2014.04.002_bib111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/scrt138","article-title":"From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells","volume":"3","author":"Redaelli","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2014.04.002_bib112","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1101\/gr.141945.112","article-title":"Pluripotent stem cells escape from senescence-associated DNA methylation changes","volume":"23","author":"Koch","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.jcyt.2014.04.002_bib113","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1474-9726.2011.00784.x","article-title":"Monitoring of cellular senescence by DNA-methylation at specific CpG sites","volume":"11","author":"Koch","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.jcyt.2014.04.002_bib114","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-62703-556-9_20","article-title":"Epigenetic biomarker to determine replicative senescence of cultured cells","volume":"1048","author":"Koch","year":"2013","journal-title":"Methods Mol Biol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324914005581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:19:42Z","timestamp":1761430782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324914005581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1465324914005581"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.002","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of Good Manufacturing Practice\u2013compliant production of bone marrow\u2013derived human mesenchymal stromal cells for immunotherapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}